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Editorial note
This series of responses was commissioned to accompa-
ny the article by Singer et al, which can be found at  [ht-
tp://www.biomedcentral.com/1472-6939/2/1] . If you
would like to comment on the article by Singer et al or
any of the responses, please email us on editorial@bi-
omedcentral.com.
Promoting national and international justice 
through bioethics
Let's highlight current weaknesses to facilitate progress
Solomon R Benatar
Singer et al [1] note that despite progress in clinical eth-
ics: (i) most medical schools lack adequate role model-
ling by a sustainable community of clinicians focussed on
the ethical concerns of patients and their families; (ii)
mechanisms for encouraging and monitoring institu-
tional ethics are inadequate, (iii) improved patient care
and outcomes do not seem to have resulted; and (iv) the
doctor patient relationship has deteriorated . While the
achievements mentioned by Singer et al should be
praised, the weaknesses noted by the authors should be
highlighted to facilitate further progress.
Surprisingly no explanation is offered for these serious
shortcomings. Several possibilities are evident to those
who both admire and are critical of North American
medicine and bioethics. First, the growth of bioethics has
taken place in an era when medicine, particularly in the
USA, has been transformed into a business, and health
care has been commodified and bureaucratised [2, 3, 4,
5]. Second, there has been loss of trust in health care pro-
fessionals and their work has been devalued [6, 7]. Third,
bioethicists may have become co-opted into the change,
and critical attitudes to the commercialisation of health
have been muted [8, 9, 10]. Fourth, the excessive focus
on autonomy in highly individualistic and self-centred
societies has deflected attention away from the impor-
tant principle of justice in health care and from consider-
ations of social justice in general [11]. Fifth, medical
research, increasingly driven by commercial interests,
has become more exploitative [12]. Finally these, and
other serious deficiencies eloquently described by Rene
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velopment' in economically deprived countries.
What can be done? First, the legitimacy of the USA's
heavily market-oriented health care system, which ac-
counts for 50% of total annual global health care expend-
iture on 5% of the world's population and yet excludes
many of its citizens (while claiming to be a standard to
which others should aspire), needs to be questioned and
contested [8, 9, 10, 13, 14, 15]. Second, the growing inter-
est in linking human rights and medical ethics should be
developed and extended beyond concern for civil and po-
litical rights, to include the social and economic rights es-
sential for re-promoting the eroded concept of civic
citizenship [16, 17]. Third, attention should be focussed
on the injustice of the global economic milieu within
which health care is being transformed [18, 19, 20], and
how this adversely affects the health of entire popula-
tions. Fourth, attempts should be made to temper exces-
sive public and professional feelings of entitlement to
every possible expensive medical intervention. Fifth, re-
newed interest is needed in professionalism, as societies
cannot flourish without professionals [21]. Finally, in-
stead of recruiting/extracting physicians from develop-
ing countries at great cost to the latter [22], the recent
example set by the Fogarty International Centre to build
capacity in research in developing countries could be em-
ulated [23]. However, the process here should include
rebuilding the capacity of privileged physicians and
bioethicists to function with high ethical ideals by send-
ing large cohorts of them to developing countries for a
year or two. There they could rediscover professional
commitment through delivering health care to deprived
people under difficult circumstances. On returning home
their mandate could be to educate their own health care
institutions and governments about the economic poli-
cies of wealthy nations that blight the lives and health of
millions of 'unseen' people [18, 19, 20, 24].
Ambitious programs are required to make real progress
in improving the ethics of the local, regional, and global
environments in which health care is delivered. Without
these I anticipate that a review in 2010 will identify even
greater lack of success in bringing ethics to bear mean-
ingfully and more universally on medical practice.
Will the yawning divide widen?
Miniscule and mundane ethical issues occupy media at-
tention, rather than truly global issues
Zulfiqar A Bhutta
The paper by Singer et al [1] is a timely review of the field
of clinical ethics, labelled by some as bioethics. Although
there has been considerable movement in this field in
general over the past decade, the slow progress on many
specific fronts is somewhat disappointing. Singer et al
highlight key advances and remaining challenges. How-
ever, much of their discourse pertains to developments
in the field of clinical ethics in Western academic circles,
and it is only in the closing section of the review that we
catch a glimpse of the global context of the ethics debate.
This relegation of the ethics debate to the pristine luxury
of Western academics and armchair philosophers is a
classic mistake, and makes many of the arguments irrel-
evant to much of the developing world.
The vital links between clinical and research ethics and
human rights are perhaps of even greater significance in
developing countries, where human rights are frequently
ignored and violated. Much too often the health debate
blithely accepts economic, health and gender inequity,
and attempts to impose an artificial code of practice on
the way health is delivered and researched in disadvan-
taged circumstances. To do so under the guise of prag-
matism and expedience is to promote the status quo and
growing inequity. I feel that much of the heat and ran-
cour generated by the debate on research into perinatal
transmission of HIV in sub-Saharan Africa also arose be-
cause of a failure to recognize the close links between hu-
man rights, gender equity, and the challenge of
practicing ethical and 'just' health care in an unjust
world. The miniscule and mundane ethical issues that
occupy media attention pale in comparison with the glo-
bal ethics of turning a blind eye to the systematic starva-
tion of a whole generation of women and children in Iraq
and Afghanistan through economic sanctions. The si-
lence on these issues by the academic community, which
defines the ground rules of clinical ethics, is incompre-
hensible. Some of us do not see these issues as divorced
from those that pertain to 'end-of-life decisions' or 'clin-
ical equipoise', problems that generate far more atten-
tion in the West. It is in this area of 'global or
international ethics' that there has been almost no real
movement over the past decade, and many of us are con-
cerned that this yawning divide will become even wider
over the next decade.
Notwithstanding the above, I am frequently struck by the
relative ease and collective wisdom with which many
communal and 'underdeveloped' societies handle ethical
dilemmas, often in a manner that is worth emulating by
others. A sharing of burden among extended closely-knit
families and communities, with faith providing the im-
portant binding force and solace, is often the key. Thus,
while the world waits for a sufficiently large pool of truly
international ethicists to develop, there is much to be
gained by increasing communication and interaction be-
tween health care providers and researchers who work in
diverse and disparate circumstances.
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matically by the time this subject is revisited again. I do
hope, however, that the enormous challenge of increas-
ing communication between disparate economies and
health systems will be accepted and addressed. We need
a better understanding of the factors that determine glo-
bal inequalities, poverty and inequities, and the way in
which ethical practice and understanding of health is
closely intertwined with these issues. It is in these cir-
cumstances of deprivation that the teaching and practice
of clinical ethics become key to the assurance of justice
and equitable sharing of the burdens and fruits of devel-
opment. In the current climate of globalisation, if trade
and tariffs are global issues then surely human rights and
ethical standards are as well.
Failure of clinical ethics to deliver on its promise
An unevaluated ethics 'industry' in North America does
not constitute a success to be emulated
Abdallah S Daar
Singer et al [1] look back at their assessment of, and pre-
dictions for, clinical ethics from 10 years ago. Historical
overviews such as these help us to navigate our way
through the high noise to signal ratio that is so character-
istic of modern ethics literature.
What is the take-home message from their revisitation?
It is that the clinical ethics project has failed to deliver on
its promise. In their assessment, Singer et al state, "if the
goal of clinical ethics is to improve patient care and out-
comes, there is scant evidence this has been achieved."
Much of the US 'ethics industry' remains unevaluated.
The role of clinical ethics consultation, which is a model
that could spread out of the USA, is particularly in need
of evaluation. Singer et al mention that the report from
the American Society for Bioethics and Humanities was
an important development, but would we have had more
data if, having identified core competences for ethics
consultations, it went on to recommend accreditation of
programmes and certification of practitioners? Very like-
ly, yes.
About 3 years ago I was asked by Stuart Youngner, a pro-
fessor in biomedical ethics, to join a group studying how
to develop and introduce clinical ethics beyond the USA.
We made a start, but were plagued by the same question
that persists today - where is the evidence that clinical
ethics as practiced in the USA improves patient care and
outcomes? The peculiar history and milieu of modern
bioethics in the USA has provided the momentum for
spreading and developing the clinical ethics consultation
model. However it is difficult to see, even in Canada, how
this could be adopted on a larger scale without more sub-
stantial evidence of effectiveness. Singer et al identified
ten years ago three key dangers of ethics consultations
and committees, namely: (1) an abrogation of moral de-
cision making by the referring physician; (2) usurpation
of moral decision making by the ethics consultant and;
(3) diffusion of responsibility within the ethics commit-
tee.
Today it is still difficult to see how these three key dan-
gers can be avoided. An additional point that Singer and
his colleagues could have addressed is the role of bioeth-
ics centres in furthering the aim of better patient care
and outcomes. This would have been of real value in this
whole important discourse.
Singer et al comment that clinical ethics has primarily
been a phenomenon of developed countries. What they
probably mean is that the conscious and professional de-
velopment of an ethics industry, as opposed to good clin-
ical ethical patient care, is primarily a US phenomenon.
For the same reasons identified by Singer et al, I am not
sure that this represents a step forward for patients.
Mark Siegler and I recently took part in an expert panel
at the American College Surgeons Congress in San Fran-
cisco, and were presented with a case that I viewed as
clearly pitting the interests of the surgeon against those
of the patient. Coming from a UK background and hav-
ing worked in developing countries, it was clear to me
that tortured ethical analysis was not called for - there
was a real conflict of interest which was not identified as
such by the surgeons involved and which was not de-
clared to the patient. When I pointed this out, the reac-
tion from the audience indicated to me that there was a
serious gap in the USA between ethical discourse, the
traditional understanding of good patient care, and rou-
tine clinical practice. It appeared to me that attempting
good, ethical patient care in a health care system whose
reimbursement method encouraged such a conflict of in-
terest between patient and physician was like cycling up-
hill with a strong wind in your face. The reaction to the
(what we now recognize as) unethical behaviour of re-
searchers in studies involving human subjects that was
publicized by Beecher (see Rothman) [25] may have
done a lot of theoretical good for human research sub-
jects, and resulted in strict research regulations on pa-
per, but in real life the system has worked against the
interests of research subjects and against good, ethical
medical care generally. This was clearly demonstrated by
the Gelsinger case, in which a teenager died while under-
going gene therapy in the hands of researchers who alleg-
edly had conflicts of interest and failed to report to the
authorities important previous research data that may
have contributed to the fatal outcome.
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tries, even in European countries. We could benefit from
looking at other systems and cultures. For example, does
the developed world have much to learn from the devel-
oping world? I would identify this as a major remaining
challenge for clinical ethics. As I have recently pointed
out [26], much of the ethical discourse is carried out in
the developed world. As more people in the developing
world become involved in the discourse, which is often
championed and led by Western practitioners, there is a
danger that we might impose value interpretations, inap-
propriate emphases, and confusion on the developing
world. The added challenge then is to develop the humil-
ity (mercifully identified by Singer et al as an important
virtue) that would allow us to listen and learn.
Singer et al correctly observe that, although public edu-
cation has grown tremendously, meaningful public en-
gagement has not. In this context, I fail to see how a
dominant media ethics voice that they identify can be
perceived as a 'major contribution to the field'? Although
some good has come from the involvement of bioethi-
cists with the media, we should be careful in praising at
least one particular characteristic of such engagement,
namely the tendency to provide an instant expert ethics
opinion. As we have learned from the 2001 presidential
election in the USA, the public is quite capable of remain-
ing patient until important matters are resolved. There is
no need to have an instant opinion for the media only a
few hours after the breaking of complex scientific news,
other than perhaps to clarify the issues for the public.
There is also a danger of having a unitary and narrow ap-
proach toward important questions when one or only a
few ethicists dominate opinion making. There is the add-
ed danger that such dominance, and its presumed wis-
dom, can cause patients to be harmed, practitioners to be
sued, and the ethics project itself to be set back.
I end by returning to patient care. It is unfortunate that
as we enter the new millennium we still need to relearn
ancient lessons [27]. Singer et al identified the need to
listen to our patients, to be better role models and to pay
more attention to developing character. It is stunning
and demoralizing to discover that the doctor-patient re-
lationship, after 20 years of clinical ethics, is 'in worse
shape than it was when the field began'. Another remain-
ing challenge is to determine whether this is true for oth-
er countries also, and not just for the USA and perhaps
Canada.
The greatest value of the contribution of Singer et al is its
demonstration that it is possible, amid all the noise, to
see these failings so clearly. We look forward to another
assessment in 2010.
Clinical ethics in the UK
The next 10 years may see a relaxing of boundaries be-
tween clinical ethics and other disciplines
Tony Hope
The past 10 years have seen major developments in clin-
ical medical ethics in the UK. A decade ago I was strug-
gling to introduce at least a minimum of ethics teaching
into one UK medical school. Now I have difficulty in
meeting the demands for such teaching. Singer et al [1]
have provided an excellent overview of the recent histo-
ry, the current position and possible future develop-
ments in clinical medical ethics. Although their
experience is from the USA, much of what they say is rel-
evant to the UK. I comment on what I see as some salient
points in UK clinical medical ethics.
Teaching
By 1990 there were two major developments in medical
ethics teaching: a number of thriving student groups that
discussed issues in medical ethics; and a rapidly growing
number of master's level courses that catered for those
doctors and nurses with an interest in the subject. What
was lacking was ethics in mainstream medical education,
both at undergraduate and postgraduate levels.
The UK General Medical Council gave an enormously
significant boost to medical ethics in 1993, as mentioned
by Singer et al, by requiring all medical schools to teach
a core of ethics. The next 10 years will see considerable
development of such teaching, and an increasing focus
on evaluation, both of students and of the teaching itself.
Continuing education in medical ethics, after qualifica-
tion, has developed much less substantially. I predict
that this will be the major new development in medical
ethics teaching over the next decade within the UK.
Clinical ethics consultation
A second major development in UK medical ethics over
the past 10 years has been the start of clinical ethics com-
mittees. [28, 29]
The first wave has developed mainly as a bottom-up re-
sponse from practising clinicians. There are signs that a
second wave may result partly from political imperatives
for mechanisms to scrutinize the ethical aspects of good
medical care.
Some of the UK committees set up by health authorities,
rather than hospitals, focus on resource allocation, be-
cause such authorities have a requirement to make the
best use of limited resources. A major restructuring of
primary care, with the formation of primary care trusts,
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tees to develop a focus on community care rather than
hospital care.
Research
Singer et al emphasized that empirical medical ethics
will be an increasingly important area over the next 10
years. The same developments are taking place in the UK
and other countries in Europe. I predict that there will be
an increasing collaboration in medical ethics research
between the USA, Europe and Australasia.
Conclusion
Over the past 1 or 2 years there has been a developing in-
terest in the medical humanities and social sciences, in-
cluding the launch in 2000 of a new UK journal - Medical
Humanities. I believe that over the next 10 years there
will be a relaxing of boundaries between medical ethics
and other disciplines. The primary goal is to solve ethical
problems, such as the huge inequities in global health.
Solutions are most likely to be found if the relevant re-
search makes use of whatever tools are helpful, rather
than being bound by a single discipline.
Getting back in line
Clinical ethics needs to address the day-to-day needs of
patients and families
Sue MacRae RN
Singer et al [1] commented that the goal of clinical ethics
is to improve patient care. In their review of clinical eth-
ics, however, they lament that the full impact of clinical
ethics on improving quality of care is yet to be realized.
Why is this?
The clinical professions have long recognized the need to
take patient values, preferences and life experiences into
account in clinical decision making and practice. To a
thoughtful clinician, good clinical practice has always
meant both good technical and ethical care [30]. Clini-
cians commonly see themselves as the patient's protector
or pride themselves as being the patient's strongest ad-
vocate. However, many clinicians are beginning to real-
ize that health care is not meeting the basic needs of
those who seek care [31–34]. For example, patients often
leave the hospital not knowing their diagnoses, or what
medications they are taking [34]. Patients' expressed lev-
els of pain are still high, especially at the end of life [35].
The amount of time patients wait for appointments and
test results is unreasonable and increasing [36]. Also, an
alarming number of patients feel like they have not been
treated with basic respect and humanity, have not been
provided with adequate emotional support, or did not
have their family involved to the extent that they wished
[37, 38].
These important patient-centered measures of quality
have been validated and widely discussed in both quality
improvement and medical literature [39, 40]. The value
of improving patient care by building systems of care
around basic human needs (as patients themselves de-
fine them) has been shown [41–44] to improve the qual-
ity of care at both the clinical and institutional levels.
Surprisingly, this approach has not made its way widely
into the clinical ethics literature. In the field of clinical
ethics, much has been written over the past 30 years re-
garding values and ethical issues from the perspectives
of health care professionals and organizations, whereas
only a few studies have systematically gathered and de-
scribed the views of patients and family members [45–
47].
Because studies have found that clinicians and others -
even family members - inaccurately judge what patients
value [48–50], understanding how patients define 'good'
or ethical care is essential if clinical ethics is to represent
a model of care that respects patients' actual values and
preferences. Clinical ethicists have a unique opportunity
to engage clinicians, organizations, patients and families
in a dialogue regarding the meaning of high quality ethi-
cal care that respects the organizational ethos and the cli-
nician's moral agency, and also accurately represents
and respects the patient's experience.
There are many ways that clinical ethicists could begin to
promote this dialogue. They could:
• conduct research to explore how patients define good
or ethical health care;
• collaborate in hospitals with clinical departments and
other departments with similar interests (such as quality
control or patient relations) to explore patient needs, val-
ues and beliefs in more depth;
• explore how definitions of high-quality ethical care giv-
en by patients and their families intersect with the defi-
nitions given by clinicians and organizations;
• investigate the barriers that face clinicians and organi-
zations in providing high-quality ethical care;
• help clinicians and organizations translate the values
and beliefs of patients and family members into their
processes and philosophy of care;
• work directly with clinicians to support their ability to
provide high-quality ethical care;
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services can be understood by patients and their families,
and directly benefit them;
• investigate the views and beliefs of patients on common
ethical issues that impact on them directly, such as com-
petency, end of life care and resource allocation; and
• conduct research to discover whether ethics policies
and guidelines, such as those surrounding informed con-
sent and end of life care, include the patient's voice, and
actually represent the values and needs of patients they
are intended to benefit.
Few would argue that meeting the basic human needs of
the people we serve should be an important ethical prior-
ity in health care. However, when we reflect on what clin-
ical ethics means today, we are likely to think more in
terms of issues that are highly controversial (eg euthana-
sia, genetic technology) or well-publicized (eg the recent
case of the conjoined twins in the UK). However, clinical
ethics today has an important opportunity to realign it-
self more directly with the original goal of clinical ethics
- to improve patient care by promoting an ethical health
care system that ensures that we meet the day-to-day hu-
man needs of our patients and their families.
Clinical ethics as a parent discipline
Attention to psychiatric clinical ethics as a subdiscipline
may alleviate one of the main causes of human suffering
and socioeconomic burden
Laura Weiss Roberts
Clinical ethics is a discipline that seeks to translate schol-
arship into meaningful ways of understanding and alle-
viating human suffering. The most basic goal of clinical
ethics is to improve patient care [51, 52], and the meth-
ods and knowledge harnessed by this discipline derive
from the fields of clinical medicine and bioethics, bio-
medical and social sciences, health policy, philosophy,
humanities, law, theology, and, more recently, popula-
tion and information sciences. Through its focus on in-
teractions and effects - between clinicians and patients,
between social policies and systems of care delivery, be-
tween scientific discoveries and society - clinical ethics
values differing perspectives and is inherently relational.
Informed by clinical experience, conceptual analysis,
and empirical evidence, clinical ethics is about benefi-
cent, practical wisdom in a world knotted with suffering.
In characterizing the 'future directions in clinical ethics'
10 years ago, Singer and his colleagues [53] defined three
requirements for the maturation of the field: strengthen-
ing of the field's conceptual and research base; pursuing
the 'professionalisation' and standardization of clinical
ethics expertise and training; and enriching the interper-
sonal communication skill set of clinical ethicists. In
their update [1], those authors define a much broader ar-
ray of challenges for the future.
They identify research issues, including improved fund-
ing opportunities for clinical ethics studies, greater inte-
gration of ethics data into 'mainstream' scientific and
clinical knowledge, and more rigorous and more diverse
inquiry. In teaching, they articulate insights echoed
throughout the education literature, such as the need for
Internet-based and adult-centred learning methods,
greater focus on the 'informal curriculum' and character
development in medicine, and augmenting our capacity
to teach and evaluate ethics knowledge and skill. With
respect to ethics consultation and committees, they ar-
gue for greater representation of clinical ethics within
the fundamental processes of health care organizations
and for more systematic study of clinical ethics interven-
tions and clinical outcomes within systems. Finally, they
suggest that the principal task ahead is to address the
profound bioethics issues, primarily health care inequi-
ties, which we now face on a global level. However, they
do not emphasize the challenges that face subdisciplines.
Psychiatric clinical ethics as a subdiscipline has an entire
universe of difficult questions that are yet to receive at-
tention.
Psychiatric clinical ethics is a small field that is evolving
in parallel with its parent discipline. As in clinical ethics,
psychiatric clinical ethics seeks to help patients, specifi-
cally people with mental illness or combined physical
and mental disorders. Psychiatric clinical ethics work is
multidisciplinary, respectful of diverse perspectives, and
focused on understanding the relations between people,
systems, and phenomena. It is enriched by theory, sub-
stantiated in data, and revealed through experience.
With only a handful of established scholars, our capacity
for research and education in psychiatric clinical ethics
has been modest in comparison with the development of
clinical ethics in internal medicine. Nevertheless, using
the criteria outlined by Singer et al, indications for
progress within the area of psychiatric clinical ethics are
good. The US National Institute of Mental Health [54]
identified studying the ethics of research involving peo-
ple with mental illness as a priority area for funding.
Similarly, the Ethical, Legal, and Social Implications
Program of the National Human Genome Research In-
stitute [55] has defined psychiatric genetic issues as a
critical domain for study. The number of psychiatrists
who are engaged in ethics inquiry has grown in recent
years, as have the number of publications in mainstream
psychiatric journals on ethics topics [56, 57]. Systematic,
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co-workers [58–60], from related disciplines over the
past 2 decades has made a profound contribution to our
understanding of informed consent and decisional ca-
pacity. Psychiatric educators have been engaged in de-
veloping innovative ethics training and in addressing
professionalism issues in medical curricula at several in-
stitutions in the USA [61–64]. Furthermore, psychiatric
ethicists and practicing psychiatrists have been long rec-
ognized for their contributions in ethics committees and
organizational leadership, and in providing expertise in
ethics and clinical decision-making through consulta-
tion-liaison services [65–69].
Despite these encouraging signs, the challenges encoun-
tered in psychiatric clinical ethics are considerable. As
has been noted by the World Health Organization, the
Surgeon General in the USA, and psychiatry leaders in-
ternationally, mental illnesses are among the top diseas-
es in the world in terms of human suffering and
socioeconomic burden [70–72]. These prevalent and se-
vere illnesses are poorly understood, however, and peo-
ple with mental illness and their families are often
gravely stigmatised and prejudicially treated [73–75].
Mentally ill populations of all ages and ethnic back-
grounds are underserved within current systems of care
in rural and urban settings, both in developed and devel-
oping countries [76–78]. Medical education gives insuf-
ficient attention to psychiatric topics, particularly across
intersecting age, sex, and cultural spectra, especially giv-
en their prevalence in clinical practice [79,80]. Public
policy related to mental illness treatment and research
has been a curious mixture of valuable insight and mis-
apprehension [81, 82]. Interestingly, despite these re-
gressive pressures, research into neurobiological,
clinical, genetic, and epidemiological aspects of mental
illness has generated extraordinary advances and new
moral dilemmas in recent years [83, 84]. Consequently,
psychiatric clinical ethics as a subdiscipline has an entire
universe of important, difficult questions that are yet to
receive systematic study [83, 85]. There are few areas so
replete with human anguish and so worthy of our atten-
tion.
Over the past decade we have witnessed the substantive
development of the field of clinical ethics. In canvassing
this extraordinary scholarly discipline, based primarily
in internal medicine, Singer et al may have omitted one
of the most important contributions clinical ethics has
made: it serves as a well-spring for sustained ethics
scholarship that seeks, in parallel with its parent disci-
pline, to enhance the care and well-being of people with
serious illnesses across diverse fields of medicine.
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Broadening the foundation
Dealing with current blind spots will help to create a
more complete vision for the future
Virginia A Sharpe
Clinical ethics - the field that Singer et al [1] have been
instrumental in establishing - importantly emphasizes
ethical concerns that are indigenous to the practice set-
ting. Unlike the current canonical approaches to medical
ethics, which are grounded in utilitarian or deontological
philosophy, clinical ethics seeks to explore medicine
from the inside, as something more than simply a fruitful
opportunity for the application of ethical theory. As Sing-
er et al state, "clinical ethics is not founded in philoso-
phy, law, or theology but, instead, is a subdiscipline of
medicine, centering upon the doctor-patient relation-
ship."
I have written sympathetically about this 'bottom-up' ap-
proach, but I take this opportunity to push the authors
and the rest of us to seek a broader foundation, one that
is still grounded in healing as a particular type of rela-
tional practice but that recognizes the following: the
moral significance of relationships beyond that of the
doctor with the patient; locations other than the 'bedside'
as key for moral learning; and the value of a plurality of
theoretical approaches. My aim is to highlight some
blind spots that should be guarded against as we look to-
ward the future of clinical ethics.
Relationships beyond that of the doctor with the patient
It is particularly frustrating at this late date that Singer et
al and many of us who write in this field continue to over-
look the moral work of other healing relationships. Are
there really good theoretical reasons to privilege the doc-
tor-patient relationship over the nurse-patient relation-
ship when describing the indigenous norms of healing?
True, the authors urge more 'interprofessional' research,
but the rationale that they offer is revealing. "Interpro-
fessional research", they say, "enriches our grasp of the
moral complexities of different professional views." By
contrast, I would argue that interprofessional research,
and interdisciplinary and transdisciplinary research play
a more fundamental role; they provide the necessary ba-
sis for sound, broadly informed research in clinical eth-
ics. If, as the authors say, it "is increasingly recognized
that the content of clinical ethics teaching needs to be
customized to the learner", then it seems equally true
that clinical ethics research should not have a default lo-
BMC Medical Ethics (2001) 2:2 http://www.biomedcentral.com/1472-6939/2/2cation for its raw material. In their discussion of the im-
portance of qualitative research methods, Singer et al
rightly note the value of ethnography. I have every expec-
tation that ethnography [86] will usefully expand our as-
sumptions regarding the normative content of clinical
ethics.
Locations other than the bedside
I entirely agree when the authors state that the goal of
clinical ethics is "to improve the quality of patient care",
and that organizational ethics entails collective responsi-
bility. It is for precisely these reasons that we must move
beyond the authors' language of ethics 'at the bedside'. I
do not disagree with the authors when they state that "we
need to develop effective methods for teaching clinical
ethics at the bedside." However, the moral quality of pa-
tient care is reflected in the patient-centred nature of in-
stitutional policies and practices, from resource
allocation to health disparities, from admission to bill-
ing, and from clinical consultation to the continuity of
care. Hence, using 'at the bedside' as shorthand is mis-
leading and potentially counterproductive. Moral skill
building in clinical ethics is required not only of those
health care providers 'at the bedside', but also of those in
policy, managerial, and support positions. To say, "clini-
cal ethics is best learned at the bedside" fosters an overly
narrow view of the location of both moral responsibility
and moral challenges in health care.
A plurality of theoretical approaches
In their account of the offerings in the conceptual foun-
dations of clinical ethics over the past decade, Singer et
al note the developments in casuistry, narrative ethics,
and feminist theory, among others. They conclude,
"Somehow, all these will need to be reconciled and put
into some rational order and relationship with each oth-
er." I would argue, by contrast, that reconciliation of the-
oretical approaches might not be a desirable goal.
Diverse theoretical offerings bring particular insights
and tell a particular story. Narrative ethics, for example,
reflect a commitment to the ways in which patients in
particular give voice to the meaning and experience of ill-
ness. Feminist ethics directs our attention to the ways in
which the distribution of power shows up in the context
of health care. The way in which these theories relate
may be oppositional, and so reconciliation may obscure
important and ongoing tensions that characterize moral
life. This is especially important as clinical ethics takes
on a life beyond its formal origins in the Anglo-American
world.
Conclusion
The account of clinical ethics offered by Singer et al is
forward looking in important respects. The authors af-
firm the increasing importance of electronic media in
clinical ethics. They rightly regard ethics as a dimension
of quality that must be subject to evaluation. They call for
increased attention to the relationship between ethics
and clinical outcomes. They anticipate the further glo-
balisation of bioethics. In the present commentary, I
have pointed to some blind spots that will need to be ad-
dressed if we are to achieve a more complete vision of
that future.
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